ROTTERDAM, The Netherlands 24 April 2024 - IMCD N.V. ("IMCD" or "Company"), a
leading distributor of speciality chemicals and ingredients, today announces
that IMCD Spain has signed an agreement to acquire 100% of the shares in
Cobapharma, S.L.U, a European distributor in the pharmaceutical and
nutraceutical industry.
Established in 2011 and headquartered in Barcelona, Spain, Cobapharma provides
an extensive portfolio of Active Pharmaceutical Ingredients (APIs) as well as
nutraceutical ingredients. With 20 employees, Cobapharma represents leading
suppliers and generated a revenue of approximately EUR 19 million in the
financial year that ended December 31, 2023.
'Cobapharma is a rapidly growing distributor in the pharmaceutical and
nutraceutical industry. Their esteemed reputation for providing high-quality
APIs and nutraceutical ingredients perfectly complements our existing portfolio.
The alignment of our business models will enhance our ability to serve our
customers and partners' comments John Robinson, Business Group Director IMCD
Pharmaceuticals.
'We are excited to join IMCD. This acquisition opens new opportunities for
Cobapharma to expand its offerings and reach a broader customer base. We look
forward to leveraging IMCD's expertise and network to accelerate our growth and
value creation to our customers', says Gianluca Galimberti, General Manager
Cobapharma.
The closing of the transaction is subject to customary (regulatory) closing
conditions and is expected to take place in the second quarter of 2024.
Attached, the press release in PDF format, the main visual and photo caption.
Â